REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
ATHENEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/29/2025
Trademark type
Word
Nice classes
5
Filing date
02/24/2017
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/02/2015
First use in commerce
02/08/2017
Drawing code
4
Owner type
03
Owner location
Buffalo, NY
Examiner
WELLS, KELLEY
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Athenex, Inc.
Representatives
JACQUELINE M LESSER BAKER & HOSTETLER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription pharmaceuticals directed to treatment of diseases and disorders affecting the circulatory systemdigestive systemexcretory systemendocrine systemintegumentary system/exocrine systemimmune system and lymphatic systemmuscular systemnervous systemrenal system and urinary systemreproductive systemrespiratory systemskeletal systemimpacting the bloodbrainheartlungskidneysstomachliverpancreasmammary glandsovariesuterustestesbladderrectumlarge intestinesmall intestinegall bladderhairskinnailsmusclesbonesjointstendonsspinethymusthyroidlymph nodesspleeneyesnosetracheaesophagusincluding anti-infectivesanti-emeticsnarcotics/analgesicspharmaceutical preparations for the treatment of infectious diseasespharmaceutical preparations for the treatment of dermatological conditionspharmaceutical products for the treatment of canceranesthesia and sedativespain reliefanti-inflammatory preparationsantiepileptic agentsmuscle relaxants
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
EXPT
EXPARTE APPEAL TERMINATED
12/31/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/31/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/31/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/31/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/31/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/31/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/13/2019
EXPI
EX PARTE APPEAL-INSTITUTED
12/13/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/13/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/13/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/14/2019
GNFR
FINAL REFUSAL E-MAILED
06/14/2019
CNFR
FINAL REFUSAL WRITTEN
06/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/04/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/02/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/21/2018
ALIE
ASSIGNED TO LIE
06/19/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/03/2017
GNSL
LETTER OF SUSPENSION E-MAILED
12/03/2017
CNSL
SUSPENSION LETTER WRITTEN
12/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2017
GNRT
NON-FINAL ACTION E-MAILED
05/30/2017
CNRT
NON-FINAL ACTION WRITTEN
05/30/2017
DOCK
ASSIGNED TO EXAMINER
05/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2017
NWAP
NEW APPLICATION ENTERED
02/28/2017
Continuous trademark protection
Get notified about every new filing that threatens ATHENEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.